Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia. (Q52668632)
Jump to navigation
Jump to search
scientific article published in March 2018
Language | Label | Description | Also known as |
---|---|---|---|
English | Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia. |
scientific article published in March 2018 |
Statements
Exploiting an Asp-Glu "switch" in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia (English)
Alexandre Puissant
Morgan Back
Daniel J DeAngelo
Richard M Stone
Xi Shi
Matthew B Robers
Thomas Machleidt
Jennifer Wilkinson
Olivier Hermine
Edward Scolnick
Yan-Ling Zhang
Jen Q Pan
Kimberly Stegmaier
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference